Sheaff Brock Investment Advisors’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-74
Closed -$13K 566
2018
Q2
$13K Hold
74
﹤0.01% 539
2018
Q1
$18K Hold
74
﹤0.01% 547
2017
Q4
$21K Hold
74
﹤0.01% 528
2017
Q3
$22K Hold
74
﹤0.01% 565
2017
Q2
$17K Hold
74
﹤0.01% 604
2017
Q1
$25K Hold
74
﹤0.01% 593
2016
Q4
$15K Hold
74
﹤0.01% 608
2016
Q3
$26K Hold
74
﹤0.01% 547
2016
Q2
$15K Hold
74
﹤0.01% 590
2016
Q1
$20K Hold
74
﹤0.01% 607
2015
Q4
$31K Buy
+74
New +$33.1K ﹤0.01% 630

Other funds holding ACGN

Sheaff Brock Investment Advisors's ACGN Position: Q3 2018 in Review

Sheaff Brock Investment Advisors sold out of Aceragen Inc (ACGN) in Q3 2018, closing a stake of 74 shares — an estimated $13K sold.

Sheaff Brock Investment Advisors first reported a position in ACGN in Q4 2015 and held it in 11 quarters. The position peaked at $31K in Q4 2015. 72 funds tracked by Wall St. Rank hold ACGN as of Q3 2018.

  • Sheaff Brock Investment Advisors reported no remaining Aceragen Inc position as of Q3 2018 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 74 Aceragen Inc shares in Q3 2018, an estimated $13K.
  • Sheaff Brock Investment Advisors first reported a position in Aceragen Inc in Q4 2015 and held it in 11 quarters.
  • Sheaff Brock Investment Advisors's Aceragen Inc position peaked at $31K in Q4 2015.
  • 72 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2018.

Based on Sheaff Brock Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.